ERBB4 is over-expressed in human colon cancer and enhances cellular transformation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ERBB4 is over-expressed in human colon cancer and enhances cellular transformation

Published:2015-04-27 Issue:7 Volume:36 Page:710-718
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:CARCIN

Author:

Williams Christopher S.,Bernard Jessica K.,Demory Beckler Michelle,Almohazey Dana,Washington Mary Kay,Smith Jesse J.,Frey Mark R.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/36/7/710/5095113/bgv049.pdf

Reference55 articles.

1. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

2. The EGF receptor family: spearheading a merger of signaling and therapeutics

3. Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

4. ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells

5. The ErbB4 Growth Factor Receptor Is Required for Colon Epithelial Cell Survival in the Presence of TNF

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing m6A Modification Factors and Their Interactions in Colorectal Cancer: Implications for Tumor Subtypes and Clinical Outcomes;2024-08-15

2. CBC-1 as a Cynanbungeigenin C derivative inhibits the growth of colorectal cancer through targeting Hedgehog pathway component GLI 1;Steroids;2024-06

3. Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach;International Journal of Molecular Sciences;2024-03-20

4. Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists;iScience;2024-02

5. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3